August 5, 2014 | Video
VBI’s eVLP Platform allows for the design of enveloped (“e”) virus-like particle (“VLP”) vaccines. eVLPs are an innovative new class of synthetic vaccines that are designed to closely mimic the structure of viruses.
Discussion of Data Presented at Society for Neuro-Oncology (SNO) 2020 Annual Meeting
Date: November 19, 2020
Presenters: Jeff Baxter, VBI CEO, and Dr. David E. Anderson, Ph.D., VBI CSO
Discussion of Data Presented at 2020 American Association for Cancer Research (AACR) Virtual Annual Meeting II
Date: June 22, 2020
Presenters: Dr. Allen Waziri, M.D., and Dr. David E. Anderson, VBI CSO
Date: October 27, 2016
Presenters: Dr. Daniel Shouval, M.D., and Dr. Florian Schödel, M.D.
Date: October 26, 2016
Presenters: Dr. David E. Anderson, VBI CSO
Date: October 25, 2016
Presenters: Dr. David E. Anderson, VBI CSO
Date: October 25, 2016
Presenters: Jeff Baxter, VBI CEO
Date: October 25, 2016
Presenters: Dr. David E. Anderson, VBI CSO
Date: October 15, 2016
Presenters: Dr. Daniel Shouval, M.D., and Dr. Florian Schödel, M.D.
Date: August 15, 2014
Presenters: Dr. David E. Anderson, VBI CSO
